Allucent Receives BARDA-Funded Project NextGen Award to Support a COVID-19 Vaccine Decentralized Clinical Trial

Posted on by

Allucent Will Conduct New Decentralized Phase IV Study Aimed at Counteracting Future Coronavirus Strains and Variants CARY, N.C., May 15, 2024 /PRNewswire/ — Allucent, a global mid-sized clinical research organization (CRO), announced today that it received a project award valued at…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.